Ideas/Opinions: The Next Biotech Buyout?


10-May-2018 16:15 PM



   The excitement for the biotech sector is back in full swing today, thanks to Eli Lilly and Co (LLY) buyout ARMO Biosciences Inc (ARMO) for $50.00 per share or $1.6 billion deal.  This is the fifth biotech buyout stocks for this year. Furthermore, investors and traders out there will look for the next buyout, here are some ideas and opinion only.  In no particular order:

  1. Spark Therapeutics Inc (ONCE)
  2. Loxo Oncology Inc (LOXO)
  3.  Abeona Therapeutics Inc (ABEO)
  4. Agios Pharmaceuticals Inc (AGIO)
  5. Global Blood Therapeutics Inc (GBT)
  6. CRISPR Therapeutics AG (CRSP)
  7. Dynavax Technologies Corp (DVAX)
  8. Alexion Pharmaceuticals (ALXN)
  9. Acorda Therapeutics Inc (ACOR)
  10. Immunogen Inc (IMGN)

   There are only five notable biotech buyout this year, we were expecting more due to the Tax Reform. Still, seven more months to go and anything can happen. We'll keep track of all the biotech buyout this year, stay tuned.

   For investors and traders like to trade biotech catalyst event, our upcoming biotech data link here

   Use the #BiotechCalculator with 83% accuracy to check results before it comes out.

   Our Macro/PDUFA events calendar

 Thanks for reading our blogs, feel free to share us your ideas and opinion. 

Disclaimer: I (we) do not hold any positions from stocks mentioned above. This is opinion and ideas only. Not to be used as investment advice. Always do your own due diligence and we are not responsible for any trade losses. 

Contact us:

Twitter: @BiotechMoney18





Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.